12.87 USD
-0.23 (-1.76%)
12.87 USD
0 (0%)
Taking everything into account, ANGO scores 2 out of 10 in our fundamental rating. ANGO was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ANGO have multiple concerns. While showing a medium growth rate, ANGO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ANGO has reported negative net income.
In the past year ANGO has reported a negative cash flow from operations.
ANGO had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ANGO reported negative operating cash flow in multiple years.
1.2 Ratios
ANGO's Return On Assets of -12.08% is in line compared to the rest of the industry. ANGO outperforms 59.68% of its industry peers.
The Return On Equity of ANGO (-17.95%) is better than 61.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.08% | ||
| ROE | -17.95% | ||
| ROIC | N/A |
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ANGO has a Gross Margin (54.15%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ANGO has remained more or less at the same level.
ANGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
ANGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ANGO has more shares outstanding
The number of shares outstanding for ANGO has been increased compared to 5 years ago.
ANGO has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.59 indicates that ANGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
ANGO has a better Altman-Z score (2.59) than 67.74% of its industry peers.
ANGO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, ANGO is in the better half of the industry, outperforming 68.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.59 |
ROIC/WACCN/A
WACC8.76%
2.3 Liquidity
A Current Ratio of 2.29 indicates that ANGO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.29, ANGO is in line with its industry, outperforming 44.62% of the companies in the same industry.
ANGO has a Quick Ratio of 1.38. This is a normal value and indicates that ANGO is financially healthy and should not expect problems in meeting its short term obligations.
ANGO has a worse Quick ratio (1.38) than 60.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 63.16% over the past year.
Looking at the last year, ANGO shows a small growth in Revenue. The Revenue has grown by 2.73% in the last year.
Measured over the past years, ANGO shows a small growth in Revenue. The Revenue has been growing by 2.06% on average per year.
EPS 1Y (TTM)63.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)2.73%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%12.18%
3.2 Future
Based on estimates for the next years, ANGO will show a very strong growth in Earnings Per Share. The EPS will grow by 54.32% on average per year.
Based on estimates for the next years, ANGO will show a small growth in Revenue. The Revenue will grow by 7.38% on average per year.
EPS Next Y-124.4%
EPS Next 2Y6.71%
EPS Next 3Y70.91%
EPS Next 5Y54.32%
Revenue Next Year8.22%
Revenue Next 2Y6.68%
Revenue Next 3Y7.1%
Revenue Next 5Y7.38%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ANGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANGO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
ANGO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ANGO is cheaper than 63.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 317.74 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ANGO's earnings are expected to grow with 70.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.71%
EPS Next 3Y70.91%
5. Dividend
5.1 Amount
No dividends for ANGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
12.87
-0.23 (-1.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.68%
Inst Owner Change7.41%
Ins Owners6.13%
Ins Owner Change17.03%
Market Cap530.24M
Revenue(TTM)300.72M
Net Income(TTM)-32.10M
Analysts84
Price Target18.87 (46.62%)
Short Float %5.5%
Short Ratio4.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.03%
Min EPS beat(2)16.56%
Max EPS beat(2)75.49%
EPS beat(4)4
Avg EPS beat(4)69.76%
Min EPS beat(4)16.56%
Max EPS beat(4)122.62%
EPS beat(8)7
Avg EPS beat(8)48.61%
EPS beat(12)9
Avg EPS beat(12)24.28%
EPS beat(16)11
Avg EPS beat(16)1.41%
Revenue beat(2)2
Avg Revenue beat(2)3.95%
Min Revenue beat(2)2.06%
Max Revenue beat(2)5.83%
Revenue beat(4)4
Avg Revenue beat(4)2.25%
Min Revenue beat(4)0.41%
Max Revenue beat(4)5.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.45%
Revenue beat(12)4
Avg Revenue beat(12)-0.95%
Revenue beat(16)5
Avg Revenue beat(16)-1.23%
PT rev (1m)0%
PT rev (3m)1.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.76 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.96 | ||
| P/tB | 4.8 | ||
| EV/EBITDA | 317.74 |
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS7.3
BVpS4.34
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.08% | ||
| ROE | -17.95% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.15% | ||
| FCFM | N/A |
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
F-Score5
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.64 | ||
| Cap/Depr | 16.39% | ||
| Cap/Sales | 1.36% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 2.59 |
F-Score5
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)17.4%
Cap/Depr(5y)17.38%
Cap/Sales(3y)1.57%
Cap/Sales(5y)1.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y-124.4%
EPS Next 2Y6.71%
EPS Next 3Y70.91%
EPS Next 5Y54.32%
Revenue 1Y (TTM)2.73%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%12.18%
Revenue Next Year8.22%
Revenue Next 2Y6.68%
Revenue Next 3Y7.1%
Revenue Next 5Y7.38%
EBIT growth 1Y29.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year139.23%
EBIT Next 3Y68.76%
EBIT Next 5Y52.46%
FCF growth 1Y-144.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-627.94%
OCF growth 3YN/A
OCF growth 5YN/A
ANGIODYNAMICS INC / ANGO FAQ
What is the fundamental rating for ANGO stock?
ChartMill assigns a fundamental rating of 2 / 10 to ANGO.
What is the valuation status for ANGO stock?
ChartMill assigns a valuation rating of 1 / 10 to ANGIODYNAMICS INC (ANGO). This can be considered as Overvalued.
Can you provide the profitability details for ANGIODYNAMICS INC?
ANGIODYNAMICS INC (ANGO) has a profitability rating of 2 / 10.
What is the financial health of ANGIODYNAMICS INC (ANGO) stock?
The financial health rating of ANGIODYNAMICS INC (ANGO) is 3 / 10.